Smith Asset Management Group »

Allogene Therapeutics shares owned by Smith Asset Management Group

Quarter-by-quarter ownership of Allogene Therapeutics (ALLO) shares owned by Smith Asset Management Group from 13F filings

Historical chart of Smith Asset Management Group investment in Allogene Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Allogene Therapeutics held by Smith Asset Management Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Allogene Therapeutics by Smith Asset Management Group

Quarter filed Position value Share count Share price at filing
2021-06-30 $2.0k 60 33.33
2021-03-31 $2.0k 60 33.33
2020-12-31 $49k 2.0k 25.00
2020-09-30 $74k 2.0k 37.56

More positions owned by Smith Asset Management Group

Apple Common Stock - Long (AAPL)
Microsoft Corp Common Stock - Long (MSFT)
Amazon.com Common Stock - Long (AMZN)
Facebook Common Stock - Long (META)
Alphabet Common Stock - Long (GOOGL)
Nvidia Corp Common Stock - Long (NVDA)
Fortinet Common Stock - Long (FTNT)
Adobe Common Stock - Long (ADBE)
United Parcel Service Common Stock - Long (UPS)
Jpmorgan Chase & Co Common Stock - Long (JPM)
Parker-Hannifin Corp Common Stock - Long (PH)
Target Corp Common Stock - Long (TGT)
Capital One Financial Corp Common Stock - Long (COF)
Paypal Holdings Common Stock - Long (PYPL)
Epam Systems Common Stock - Long (EPAM)

View all positions for Smith Asset Management Group

Top funds holding Allogene Therapeutics

Tpg Gp A
Vanguard Group
Jpmorgan Chase & Co
PRIMECAP Management Company
Citadel Advisors
Goldman Sachs Group
T. Rowe Price Associates
Two Sigma Investments
Millennium Management
Vida Ventures Advisors
Dimensional Fund Advisors
Two Sigma Advisers
Caxton Associates
Nordea Investment Management Ab
Charles Schwab Investment Management

View all funds holding Allogene Therapeutics